In the wake of research suggesting a skin-cancer drug may have benefits in Alzheimer's disease, physicians and advocacy groups are getting a flurry of calls from patients seeking to use the drug off-label. (Source: WSJ.com: Health)

Läs hela artikeln: http://www.medworm.com/index.php?rid=5677088&cid=u_0_34_f&fid=36225&url=http://feedproxy.google.com/~r/wsj/xml/rss/3_7089/~3/xnKAV21rpfU/SB10001424052970204642604577215382600942356.html

< Föregående		Nästa >